Literature DB >> 9737333

Identification of metabolites of nerve agent VX in serum collected from a victim.

H Tsuchihashi1, M Katagi, M Nishikawa, M Tatsuno.   

Abstract

A human serum sample collected from a victim of the Osaka VX incident was analyzed according to our developed technique for metabolites of VX. Gas chromatography-mass spectrometry (GC-MS) in full-scan electron impact and chemical ionization modes were used, and, for more reliable confirmation, GC-MS-MS was also employed. In the serum sample, both ethyl methylphosphonic acid and 2-(diisopropylamino-ethyl)methyl sulfide were detected. These results indicated that the techniques using GC-MS and GC-MS-MS were applicable to biological samples such as serum. These results also provide the first documented, unequivocal identification of the specific metabolites of VX in victim's serum and, furthermore, clarify a part of the metabolic pathway of VX in the human body.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737333     DOI: 10.1093/jat/22.5.383

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  9 in total

1.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  Quantitation of five organophosphorus nerve agent metabolites in serum using hydrophilic interaction liquid chromatography and tandem mass spectrometry.

Authors:  Elizabeth I Hamelin; Nicholas D Schulze; Rebecca L Shaner; Rebecca M Coleman; Richard J Lawrence; Brian S Crow; E M Jakubowski; Rudolph C Johnson
Journal:  Anal Bioanal Chem       Date:  2014-03-15       Impact factor: 4.142

3.  Evaluation of Multiple Blood Matrices for Assessment of Human Exposure to Nerve Agents.

Authors:  Nicholas D Schulze; Elizabeth I Hamelin; W Rucks Winkeljohn; Rebecca L Shaner; Brian J Basden; B Rey deCastro; Brooke G Pantazides; Jerry D Thomas; Rudolph C Johnson
Journal:  J Anal Toxicol       Date:  2016-02-08       Impact factor: 3.367

4.  Investigation of dried blood sampling with liquid chromatography tandem mass spectrometry to confirm human exposure to nerve agents.

Authors:  Rebecca L Shaner; Rebecca M Coleman; Nicholas Schulze; Kelsey Platanitis; Ashli A Brown; Craig Seymour; Pearl Kaplan; Jonas Perez; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Anal Chim Acta       Date:  2018-06-20       Impact factor: 6.558

5.  Retrospective detection for V-type OPNAs exposure via phosphonylation and disulfide adducts in albumin.

Authors:  Jin Wang; Fengjuan Sun; Xiaogang Lu; Runli Gao; Chengxin Pei; Hongmei Wang
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

6.  Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.

Authors:  Yuan Yao; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2012-10-23       Impact factor: 3.162

7.  Extended retrospective detection of regenerated sarin (GB) in rabbit blood and the IMPA metabolite in urine: a pharmacokinetics study.

Authors:  Merav Blanca; Avital Shifrovitch; Shlomit Dachir; Shlomi Lazar; Maor Elgarisi; Hagit Prihed; Shlomi Baranes; Inbal Egoz; Meir Avraham; Hani Dekel Jaoui; Ohad Mazor; Shai Dagan; Avi Weissberg
Journal:  Arch Toxicol       Date:  2021-05-25       Impact factor: 5.153

Review 8.  Selected Political Criminal Poisonings in the Years 1978-2020: Detection and Treatment.

Authors:  Zuzanna Brunka; Jan Ryl; Piotr Brushtulli; Daria Gromala; Grzegorz Walczak; Sonia Zięba; Dorota Pieśniak; Jacek Sein Anand; Marek Wiergowski
Journal:  Toxics       Date:  2022-08-12

9.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.